• Academy
    • Find lectures & contributors
    • Webinars on-demand
    • Online courses
    • 89th EAS Congress, Helsinki 2021
  • Become an EAS member
    Sign in
    • Academy
      • Find lectures & contributors
      • Webinars on-demand
      • Online courses
      • 89th EAS Congress, Helsinki 2021
    • Become an EAS member
    • Sign in

    Kausik Ray

    Contributions

    The role of new lipid lowering drugsEAS AC on FHThe population burden of FH- The need to close the gapEAS AC on FHHDL, non HDL cholesterol and TG - a role in atherosclerosis?EAS AC in LipidologyFamilial hypercholesterolemia detection and treatment and the EAS InitiativesEAS AC in LipidologyWhat do we know so far about bempedoic acid?88th EAS Congress 2020siRNA based approaches targeting hepatic synthesis of PCSK988th EAS Congress 2020Risk Prediction for Add on Lipid Modulating Therapy87th EAS Congress 2019Why TG-rich lipoproteins-non-HDL-Cholesterol matter when assessing CVD risk? - Introduction85th EAS Congress 2017Familial hypercholesterolaemia85th EAS Congress 2017Cardiovascular risk assessment and lipid lowering for patients with DM - what do the guidelines say?2019 ESC-EAS Dyslipidaemia Guidelines
    © 2022 - EAS Digital

    Report

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this